Sunshine Biopharma (SBFMW) Research & Development (2016 - 2025)
Historic Research & Development for Sunshine Biopharma (SBFMW) over the last 12 years, with Q3 2025 value amounting to $119298.0.
- Sunshine Biopharma's Research & Development fell 559.03% to $119298.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $680079.0, marking a year-over-year decrease of 5752.05%. This contributed to the annual value of $933902.0 for FY2024, which is 4967.74% down from last year.
- Latest data reveals that Sunshine Biopharma reported Research & Development of $119298.0 as of Q3 2025, which was down 559.03% from $196232.0 recorded in Q2 2025.
- Over the past 5 years, Sunshine Biopharma's Research & Development peaked at $816328.0 during Q4 2023, and registered a low of $41763.0 during Q4 2022.
- In the last 5 years, Sunshine Biopharma's Research & Development had a median value of $215277.0 in 2025 and averaged $252874.0.
- In the last 5 years, Sunshine Biopharma's Research & Development surged by 517766.2% in 2021 and then crashed by 8171.42% in 2024.
- Over the past 5 years, Sunshine Biopharma's Research & Development (Quarter) stood at $91198.0 in 2021, then crashed by 54.21% to $41763.0 in 2022, then skyrocketed by 1854.67% to $816328.0 in 2023, then plummeted by 81.71% to $149272.0 in 2024, then decreased by 20.08% to $119298.0 in 2025.
- Its Research & Development stands at $119298.0 for Q3 2025, versus $196232.0 for Q2 2025 and $215277.0 for Q1 2025.